Enhanced efficacy of anti-tumor liposomal doxorubicin by hyperthermia

Annual International Conference of the IEEE Engineering in Medicine and Biology - Proceedings

Volumn , Issue , 2006, Pages 4354-4357

  Liu, Ping ^a   Xu, Lisa Xuemin ^a,b   Zhang, Aili ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b PURDUE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOTHERAPY; DRUG DELIVERY; HISTOLOGY; NANOPARTICLES; TISSUE; TUMORS;

ANTI-TUMOR DRUGS; HYPERTHERMIA; LIPOSOMAL DOXORUBICIN;

LIPOSOMES;

ANTINEOPLASTIC AGENT; ANTINEOPLASTIC ANTIBIOTIC; DOXORUBICIN; DRUG CARRIER;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; CONFOCAL MICROSCOPY; DRUG DELIVERY SYSTEM; HYPERTHERMIC THERAPY; METABOLISM; MOUSE; NECROSIS; NEOPLASM; NUCLEOLUS; NUDE MOUSE; THEORETICAL MODEL;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS; CELL NUCLEOLUS; DOXORUBICIN; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; HYPERTHERMIA, INDUCED; MICE; MICE, INBRED BALB C; MICE, NUDE; MICROSCOPY, CONFOCAL; MODELS, THEORETICAL; NECROSIS; NEOPLASMS;

EID: 34047182107     PISSN: 05891019     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.1109/IEMBS.2006.259729     Document Type: Conference Paper

References (30)

1. Torchilin VP. Drug targeting. Eur J Pharm Sci 2000; 11 Suppl 2:S81-91.
2. Allen TM, Sapra P. Ligand-targeted liposomal anticancer drugs. Prog Lipid Res 2003; 42(5): 439-62.
3. Woodle MC. Sterically stabilized liposome therapeutics. Adv Drug Deliv Rev 1995; 16: 249-265.
4. Harashima H, Kiwada H. Liposomal targeting and drug delivery: Kinetic consideration. Adv Drug Rev 1996; 19: 425-444.
5. Yuda T, Pongpaibul Y, Maruyama K, et al. Activity of amphipathic polyethylene glycol to prolong the circulation time of the liposomes. J Pharm Sci Jpn 1999; 59: 32-42.
6. Torchilin VP, Omelyanenko VG, Papisov MI, et al. Poly(ethyleneglycol) on the liposome surface: on the mechanism of polymer-coated liposome longevity. Biochem Biophys Acta 1994; 1195:11-20.
7. Janzen J, Song X, Brooks DE. Interfacial thickness of liposomes containing Poly(ethyleneglycol)-cholesterol from electophoresis. Biophys J 1996; 70: 313-320.
8. Sadzuka Y, Nakai S, Miyagishima A, et al. The effect of dose on the distribution of adriamycin encapsulated in olyethyleneglycol-coated liposomes. J Drug Target 1995; 3: 31-37.
9. Maruyama K, Ishida O, Takizawa T, et al. Possibility of active targeting to tumor tissues with liposomes. Adv Drug Deliv Rev 1999; 40: 89-102.
10. Gill PS, Espina BM, Muggia F, et al. Phase I / II clinial and pharmacokinetic evaluation of liposomal daunorubicin. J Clin Oncol 1995; 13: 996-1000.
11. Allen TM, Hansen C, Martin F, et al. Liposomes containing synthetic lipid derivatives of polyethylene glycol show prolonged circulation half-lives in vivo. Biochim Biophys Acta 1991; 1066: 29-36.
12. Eksborg S, Stendahl U, and Lonroth U. Comparative pharmacokinetic study of adriamycin and 4'-epi-adriamycin after their simultaneous intravenous administration. Eur J Clin Pharmacol 1986; 30: 629-631.
13. Booser DJ, Hortobagyi GN. Anthracycline antibiotics in cancer therapy: Focus on drug resistance Drugs 1994; 47: 223-258.
14. Yasuyuki S, Sadao H. Does the amount of an antitumor agent entrapped in liposomes influence its tissue distribution and cell uptake? Cancer Letters 1998; 131: 163-170.
15. Safra T, Muggia F, Jeffers S, et al. Pegylated liposomal doxorubicin (doxil): reduced clinical cardiotoxicity in patients reaching or exceeding cumulative doses of 500 mg/m2. Ann Oncol 2000; 11(8): 1029-33.
16. Bally MB, Nayar R, Masin D, et al. Liposomes with entrapped doxorubicin exhibit extended blood residence times. Biochim Biophys Acta 1990; 1023(1): 133-9.
17. Gabizon AA.Selective tumor localization and improved therapeutic index of anthracyclines encapsulated in long-circulating liposomes. Cancer Res 1992; 52(4): 891-6.
18. Ning S, Macleod K, Abra RM, et al. , Hyperthermia induces doxorubicin release from long-circulating liposomes and enhances their anti-tumor efficacy. Int J Radiat Oncol Biol Phys 1994; 29: 827-834.
19. Gaber MH, Wu NZ, Hong K, et al., Papahadjopoulos D, Thermosensitive liposomes: extravasation and release of contents in tumor microvascular networks. Int J Radiat Oncol Biol Phys 1996; 36: 1177-1187.
20. Maruyama K, Unezaki S, Takahashi N, et al., Enhanced delivery of doxorubicin to tumor by long-circulating thermosensitive liposomes and local hyperthermia. Biochim Biophys Acta 1993; 1149: 209-216.
21. Embree L, Gelmon KA, Lohr A, et al., Chromatohraphic analysis and pharmacokinetics of liposome-encapsulated doxorubicin in nonsmall cell lung cancer patients, J. Pharm Sci 1993; 82: 627-634.
22. Nicholis G, Clark BJ, Brown JE , Solid-phase extraction and optimized separation of doxorubicin, epirubicin and their metabolites using reversed-phase high-performance liquid chromatography, J. Pharmaceut Biomed Anal 1992; 10: 949-957.
23. Sadzuka Y, Nakai S, Miyagishima A, et al., The effect of dose on the distribution of adriamycin encapsulated in polyehyleneglycol-coated liposomes, J Drug Targeting 1995; 3: 31-37.
24. Liu, Ping, Zhang Aili, Xu, Yuhong Xu, Lisa X. Study of non-uniform nanoparticle liposome extravasation in tumor, International Journal of Hyperthermia 2005; 21 (3) : 259-270
25. Hope MJ, Bally MB, Webb G, Cullis PR. Production of large unilamellar vesicles by a rapid extrusion procedure: Characterization of size distribution, trapped volume and ability to maintain a membrane potential. Biochim Biophys Acta 1985; 812:55-65.
26. Mayer, L. D., Tai, L. C., Bally, M. B., Mitilenes, G. N., Ginsberg, R. S. and Cullis, P. R.: Characterization of liposomal systems containing doxorubicin entrapped in response to pH gradients. Biochim Biophys Acta 1990; 1025: 143.
27. Huang Q, Shan S, Braun RD, Lanzen J, Anyarambhatla G, Kong G, et al. Noninvasive visualization of tumor in rodent dorsal skin window chambers. Nat Biotechnol 1999, 17: 1033-1035.
28. Lankelma J, Luque RF, Dekker H, et al., A mathematical model of drug transport in breast cancer, Micro. Res., 2000, 59: 149-161.
29. Brown EB, Boucher Y, Nasser S, et al., Measurement of macromolecular diffusion coefficients in human tumors, Micro. Res., 2004, 67: 231-236.
30. El-Kareh AW, Secomb TW. A mathematical model for comparison of bolus injection, continuous infusion, and liposomal delivery of doxorubicin to tumor cells. Neoplasia. 2000, 2(4): 325-38.